Evidence map›Paper›PMID 30886932›Full record

ArticleHeliyon2019

Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of

Ryuichi Nakano, Akiyo Nakano, Michiko Abe, Noriyuki Nagano, Miwa Asahara, Taiji Furukawa, Yasuo Ono, Hisakazu Yano, Ryoichi Okamoto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A One Health Perspective onMicroorganisms · 2026
    Review
  2. Article
  3. First Report of CTX-M-32 and CTX-M-101 inAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ryuichi NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
Akiyo NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
Michiko AbeDepartment of Medical Laboratory Sciences, Kitasato University School of Allied Health Sciences, Sagamihara, Kanagawa, Japan.
Noriyuki NaganoDepartment of Health and Medical Sciences, Shinshu University, Graduate School of Medicine, Matsumoto, Nagano, Japan.
Miwa AsaharaDepartment of Central Clinical Laboratory, Teikyo University Hospital, Itabashi-Ku, Tokyo, Japan.
Taiji FurukawaDepartment of Central Clinical Laboratory, Teikyo University Hospital, Itabashi-Ku, Tokyo, Japan.
Yasuo OnoDepartment of Microbiology and Immunology, Teikyo University School of Medicine, Itabashi-Ku, Tokyo, Japan.
Hisakazu YanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
Ryoichi OkamotoDepartment of Microbiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluoroquinolone (FQ) and cephalosporin (CEP) resistance among Enterobacteriaceae has been increasingly reported. FQ resistance occurs primarily through mutations in DNA gyrase (

Indexed as

EpidemiologyMicrobiology

Identifiers

PMID30886932
PMCPMC6403068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.